Ser(203) as well as Ser(204) and Ser(207) in fifth transmembrane domain ofthe human beta(2)-adrenoceptor contributes to agonist binding and receptoractivation
T. Sato et al., Ser(203) as well as Ser(204) and Ser(207) in fifth transmembrane domain ofthe human beta(2)-adrenoceptor contributes to agonist binding and receptoractivation, BR J PHARM, 128(2), 1999, pp. 272-274
We examined the contribution of Ser(203) of the human b(2)-adrenoccptor (b(
2)-AR) to the interaction with isoprenaline. The affinity of (-)-isoprenali
ne was reduced by substitution of an alanine for Ser(203), as well as for S
er(204) and Ser(207). An (-)-isoprenaline derivative with only one hydroxyl
group, at the meta-position, showed reduced affinity for wild-type b(2)-AR
and S207A-b(2)-AR and even lower affinities for S203A-b(2)-AR and S204A-b(
2)-AR. By contrast, an (-)-isoprenaline derivative with only a pa, a-hydrox
yl group showed reduced affinity for wild-type b(2)-AR but the serine to al
anine mutations did not cause further decreases. The EC50 value for cyclic
AMP generation in response to (-)-isoprenaline was increased. by about 120
fold, for each alanine-substituted b(2)-AR mutant. These results suggest th
at Ser(203) of the human b(2)-AR is important for both ligand binding and r
eceptor activation.